Do you value our podcasts?
Do you value our Drug-Development Pipeline?
Do you value our news stories?
Do you find MSDF invaluable?
Do you value our data visualizations?
Welcome to the Multiple Sclerosis Discovery Forum
Do you find MSDF invaluable? If so, please help us continue by making a tax-deductible donation NOW.
A recent study found that patients taking dimethyl fumarate (Tecfidera) had low counts of CD8+ T cells, though their overall levels of lymphocytes were within the normal range. The findings suggest that physicians may want to monitor specific lymphocyte levels in addition to doing full blood cell counts.
Eight top papers showcase scientific progress in multiple sclerosis research in 2014
Tools that will help investigators conceive and perform experimental work:
The Data Visualization section presents MS-related data in new ways, making it easy for viewers to discover unexpected relationships
Our latest data visualization displays 142 ongoing MS clinical trials and allows you to sort the trials 10 different ways, including by phase, by population, by compound, and by sponsor.
- Drug-Development Pipeline consolidates key information about compounds under investigation for therapeutic use
We've recently updated information on four trials and added 22 other pieces of information. The drugs with important additions and changes are daclizumab, dimethyl fumarate, fingolimod, glatiramer acetate, interferon β-1a, interferon β-1b, and natalizumab.
- Tissue Repositories lists features of the world's tissue repositories and brain banks, including rules of engagement and contact information
- MSGene provides a comprehensive, unbiased and regularly updated collection of genetic association studies performed on multiple sclerosis phenotypes
- Clinical Trials lists sources of information about MS clinical trials
Meetings and Events catalogs future and past meetings of interest to the MS-research community
- Funding Opportunities provides information about where to obtain grants
- Jobs offers descriptions of available positions
Member Directory displays profiles of MS-research community members
Bulletin Board allows MSDF members to post notices
Useful Links lists helpful resources elsewhere on the web
Amyloid has potent anti-inflammatory abilities which may explain what it is trying to do in Alzhe
Does anyone know anything more about this?
When will this study be completed?
Most Popular Content
- Novel Remyelination Assay Allows High-Throughput Drug Screening
- Low Testosterone Linked to Disability in Men With MS
- Explaining Fingolimod’s Fatal Flaw
- Phase 1 Results Reported for Anti-LINGO-1 Remyelination Agent
- Physical Activity Associated With Improved Quality of Life in People With MS
- Beyond Reasonable Doubt: The vitamin D piece of the MS puzzle
- MS Research Roundup: July 28, 2014
- Talking to Reporters: 13 Tips for Researchers
- Rare Family Cluster of MS Reveals New Clues
- MS Research Roundup: March 31, 2014
- MS Patient, Ph.D.: Lightning (and the Ice Bucket Challenge) Doesn’t Strike Twice
- MS Research Roundup: April 8, 2014
- Make Way for Another MS Model?
- Peripheral B Cell Activation May Drive CNS Autoimmunity in MS
- Epigenetics in MS: A Primer
- Clinical Trials in Multiple Sclerosis
- MS Patient, Ph.D.: Calling Dr. Thomas Hale
- MS Research Roundup: August 21, 2014
- New MS Clinical Course Descriptions Reflect Disease Activity
- Myelin and Axons Don’t Form a Perfect, Uniform Union
- Sniffing Out Demyelination
- Remyelination: Are Exosomes Containing microRNA the Answer?
- MS Research Roundup: August 29, 2014
- More Than Meets the Eye
- Switches to Fingolimod, Natalizumab Show Similar Efficacy
- MS Research Roundup: August 18, 2014
- “Long Life” Protein Klotho Powers Remyelination in Mice
- Altered Immunity, Crippled Neurons
- MS Research Roundup: March 21, 2014
- Decoding Brain Disease
- Pregnancy’s Secret Weapon?
- The Paradox of Daclizumab
- Scientific Literature TreeMap
- MS Patient, Ph.D.
- Can Gut Microbes Provide Answers About MS?
- PPMS vs. RRMS: A Distinction Without a Difference?
- A Complementary Approach to Treating MS?
- Benign MS Expresses Itself
- MS Research Roundup: April 30, 2014
- MS Research Roundup: August 13, 2014
- MS Research Roundup: February 12, 2014
- MS Research Roundup: February 26, 2014
- Viral Villain
- MS Patient, Ph.D.: PPMS: A New Hope?
- What’s the Role of Myelin Oligodendrocyte Glycoprotein in NMO?
- Portable Neuromodulation Device May Improve Walking in MS Patients
- Small Internal Jugular Veins Linked to Severe MS
- Please log in or email us
- Innate Differences in Demyelination
- Transdermal Myelin Peptides May Be Safe, Effective in MS
- The Many Faces of B Cells
- MS Research Roundup: May 27, 2014
- MS Research Roundup: September 29, 2014
- “No great discovery was ever made without a bold guess,” Sir Isaac Newton
- Is Cognitive MS a Distinct Entity?
- Single Calcitriol Dose Beats Back EAE in Mice
- Serum Vitamin D Levels Predict Severity of MS
- Blood Serum From Relapsing MS Patients May Damage the Blood-Brain Barrier
- Interferon β and Glatiramer Acetate Are Clinically Similar, Says Cochrane Meta-Analysis
- International Progressive MS Alliance Announces New Research Grants
- Phase 2 Trial Suggests RPC1063 Is as Effective as—and Safer Than—Fingolimod
- MS Research Roundup: October 3, 2014
- MS Research Roundup: October 28, 2014
- MS Family Planning 101: Should DMTs Be Discontinued Before and During Pregnancy?
- Some Astrocytes Appear to Promote Progressive MS
- Multiple Sclerosis Discovery Podcast
- Type 1 Diabetes Linked to Higher MS Risk Among Youth
- Autologous Stem Cell Transplant Effective in Inflammatory RRMS; Mechanism Emerging
- New MS Drug Candidate From Zebrafish Screen Targets IGF-1R Pathway
- EDSS Alternative in an iPad
- Corticosteroids Ineffective for Many With Relapsing MS
- Signaling Pathway Important in Colon Cancer Implicated in Maturational Arrest of OPCs
- Lower Risk of MS in People With HIV
- Genetic Marker May Underlie Sex Difference in MS Susceptibility
- Comorbidities, Both Physical and Mental, Are Pervasive in MS
- Sex Differences in MS Are Genetic, Not Just Hormonal
- MS Patient, Ph.D.: Axes of Access Don’t Intersect for the Disabled Patient
- Kir4.1 Potassium Channels in MS: Discrepant Results From Two Studies
- Antigen-Specific Therapy for MS Passes Safety Test
- Microglia, Molecularly Defined
- Precision medicine in chronic disease management: The MS BioScreen.
- RRMS and CIS—Baseline Characteristics
- National MS Society Partners With Accelerated Cure Project Online Forum to Drive Progress
- Optical Coherence Tomography: New Evidence Lends Support for MS Diagnosis
- A Better Interferon?
- MS Research Roundup: June 19, 2014
- 159 Genetic Variants Now Known to Be Associated With MS
- MS Research Roundup: October 16, 2014
- New Myelin Required to Learn a New Task
- Deep Brain Stimulation Helpful in Some Patients With MS Tremor
- Immune Attack: Primary or Secondary?
- MS and South hemisphere
- Phase 1 Trial of Stem Cells Begins in MS
- Video Game Revs Up Brain Power
- Genomic Double Play
- Partnership and Consent in MS Decision-Making
- MRI Detects Early MS-Like Changes in Rare Eye Disease
- Old Drug May Wield New Power
- Oral Contraceptive Use Linked to Less Severe Relapsing-Remitting MS
- MS Family Planning 201: Breastfeeding, DMTs, and the Risk of Postpartum Relapse
- Interferon beta-1a